Evidence map›Paper›PMID 41268319›Full record

ReviewJournal of ginseng research2025

Exploring the potential of ginseng-derived compounds in treating cancer cachexia.

Phuong Thi Ho, Ika Agus Rini, Phuong Thi Hoang, Taek Kyun Lee, Sukchan Lee

Abstract readReview
In one paragraph

Review in Journal of ginseng research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Advances in Research onInternational journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Journal of ginseng research · 2026
    Review
  5. Ginsenosides fromJournal of ginseng research · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Phuong Thi HoDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Ika Agus RiniDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Phuong Thi HoangDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Taek Kyun LeeEcological Risk Research Department, Korea Institute of Ocean Science & Technology, Geoje, 53201, Republic of Korea.
Sukchan LeeDepartment of Integrative Biotechnology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cachexia is a complex wasting syndrome characterized by significant loss of body weight and muscle mass in patients with advanced cancer. The disease is associated with increased systemic inflammation, altered neurohormonal signaling, and, in particular, an increased catabolic rate in muscle and adipose tissue. Generally, cancer cachexia leads to weakness, reduced quality of life, decreased tolerance to cancer therapies, and poor survival. Despite considerable research effort, effective treatments for cancer cachexia remain limited, highlighting the need for innovative therapeutic strategies. Recently, there has been growing interest in plant-derived treatments for cancer cachexia. These natural remedies have shown the potential to attenuate muscle wasting, stimulate food intake, improve energy balance, and alleviate systemic inflammation associated with the condition. This review summarizes the impact of recent studies on ginseng-derived compounds on cancer cachexia, explores their underlying mechanisms, and expands our understanding of potential therapeutic approaches for cachexia.

Indexed as

Cancer cachexiaGinsenosideInflammationMuscle wastingPanax ginseng

Identifiers

PMID41268319
PMCPMC12629716

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.